0 items USD 0.00Search
- Did you mean
- crohn disease
Your search for "Crohn’s disease" gave back 31600 results.
Crohn's disease is a type of inflammatory bowel disease (IBD). It causes swelling of the tissues (inflammation) in your digestive tract, which...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
The global Crohn's Disease Diagnostic and Therapeutic market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030,...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global IBD (Ulcerative Colitis and Crohn's Disease) Treatment market is projected to grow from US$ million in 2023 to US$ million by 2029,...
Catalog:
MRRPB5
June 2023
Price: USD 4,900.00
Highlights The global IBD (Ulcerative Colitis and Crohn's Disease) Treatment market was valued at US$ million in 2022 and is anticipated to...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Crohn’s disease refers to long term inflammatory bowel disease, which causes inflammation of the lining of the digestive tract. It affects the large...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Highlights The global Crohn's Disease Treatment Drug market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029,...
Catalog:
MRRPB5
May 2023
Price: USD 2,900.00
The Tysabri Drugs industry plays a vital role in the field of neuroscience by providing innovative solutions for the treatment of multiple sclerosis...
Catalog:
HJResearch
June 2023
Price: USD 3,200.00
Inflammatory bowel disease is a group of medical indication that causes chronic inflammation in the gastrointestinal tract. The inflammatory bowel...
Catalog:
MRRPB5
January 2024
Price: USD 2,900.00
The global Inflammatory Bowel Disease (IBD) Treatment market size was valued at US$ 1579.4 million in 2023. With growing demand in downstream market...
Catalog:
LPI
March 2024
Price: USD 3,660.00
Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Infliximab is a monoclonal anti tumor necrosis factor alpha antibody used in the treatment of a wide variety of inflammatory conditions such as...
Catalog:
MRRPB5
June 2023
Price: USD 2,900.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
The global Remicade (Infliximab) Monoclonal Antibody market size is projected to grow from US$ 2494.5 million in 2022 to US$ 3703.9 million in 2029;...
Catalog:
LPI
June 2023
Price: USD 3,660.00
Inflammatory bowel disease is a condition generally caused when immune system attacks harmless bacteria, virus, or food in the intestine. The most...
Catalog:
MRRPB5
October 2023
Price: USD 2,900.00
Infliximab (trade names Remicade among others) is a chimeric monoclonal antibody biologic drug that works against tumor necrosis factor alpha (TNF-α...
Catalog:
MRRPB5
November 2023
Price: USD 3,350.00
